TG Therapeutics | SCHULD



Debt Veränderung Datum
AbbVie USD 69.89B 2.74B 2025-03
Alaunos Therapeutics USD 0 0 2024-12
Amgen USD 56.2B 1.18B 2025-06
Ardelyx USD 206.64M 55.79M 2025-06
Arrowhead Research USD 388.24M 21.18M 2025-03
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.59B 296.8M 2025-06
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Dynavax Technologies USD 260.51M 36.65M 2025-03
Gilead Sciences USD 24.95B 6M 2025-06
J&J USD 52.25B 15.62B 2025-03
Novartis USD 31.27B 12M 2025-03
PTC Therapeutics USD 286.01M 2.12B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Roche Holding CHF 34.44B 5.23B 2024-06
TG Therapeutics USD 8.98M 235.45M 2025-03
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


TG Therapeutics SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.